These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Regulatory issues relating to the use of recombinant vectors in production of human vaccines. Marcus-Sekura CJ Dev Biol Stand; 1994; 82():107-12. PubMed ID: 7958464 [TBL] [Abstract][Full Text] [Related]
12. Location of topics in NIH Guidelines for research involving recombinant DNA molecules. Recomb DNA Tech Bull; 1984 Jun; 7(2):93-5. PubMed ID: 6548040 [No Abstract] [Full Text] [Related]
13. DNA rules kept to head off new laws. Sun M Science; 1982 Feb; 215(4536):1079-80. PubMed ID: 7063840 [TBL] [Abstract][Full Text] [Related]
14. NIH director unlikely to grant exemption from controls for DNA experiments. Nature; 1979 Nov; 282(5734):3. PubMed ID: 503186 [No Abstract] [Full Text] [Related]
16. Recombinant DNA research; proposed actions under guidelines. National Institutes of Health. Recomb DNA Tech Bull; 1987 Sep; 10(3):90-104. PubMed ID: 3685453 [TBL] [Abstract][Full Text] [Related]
17. PROPOSED AMENDMENTS OF SECTION III-A OF NIH GUIDELINES. Recomb DNA Tech Bull; 1984 Jun; 7(2):78-80. PubMed ID: 6548038 [No Abstract] [Full Text] [Related]
18. Questions concerning boundaries for NIH and RAC oversight. Recomb DNA Tech Bull; 1984 Mar; 7(1):33. PubMed ID: 6547239 [No Abstract] [Full Text] [Related]
19. Proposed amendments of the NIH guidelines and comments by the director, NIAID. Recomb DNA Tech Bull; 1984 Mar; 7(1):32-3. PubMed ID: 6547238 [No Abstract] [Full Text] [Related]
20. Select agents. Heightened security or neocolonial science? Stone R Science; 2004 Dec; 306(5705):2177-8. PubMed ID: 15618498 [No Abstract] [Full Text] [Related] [Next] [New Search]